Stockreport

Precision BioSciences Presents Preclinical PBGENE-DMD Data Highlighting Durable Dystrophin Expression and Functional Benefit at the Muscular Dystrophy Association Clinical & Scientific Con...

Precision BioSciences, Inc.  (DTIL) 
Last precision biosciences, inc. earnings: 11/12 07:15 am Check Earnings Report
PDF – Findings reinforce differentiated in vivo gene editing approach designed for durable functional muscle improvement through satellite cell editing –– PBGENE-DMD treatme [Read more]